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Abstract
Background: Mendelian randomization uses genetic variants, assumed to be instrumen-
tal variables for a particular exposure, to estimate the causal effect of that exposure on
an outcome. If the instrumental variable criteria are satisfied, the resulting estimator is
consistent even in the presence of unmeasured confounding and reverse causation.
Methods: We extend the Mendelian randomization paradigm to investigate more com-
plex networks of relationships between variables, in particular where some of the effect
of an exposure on the outcome may operate through an intermediate variable (a medi-
ator). If instrumental variables for the exposure and mediator are available, direct and
indirect effects of the exposure on the outcome can be estimated, for example using
either a regression-based method or structural equation models. The direction of effect
between the exposure and a possible mediator can also be assessed. Methods are illus-
trated in an applied example considering causal relationships between body mass index,
C-reactive protein and uric acid.
Results: These estimators are consistent in the presence of unmeasured confounding if,
in addition to the instrumental variable assumptions, the effects of both the exposure on
the mediator and the mediator on the outcome are homogeneous across individuals and
linear without interactions. Nevertheless, a simulation study demonstrates that even con-
siderable heterogeneity in these effects does not lead to bias in the estimates.
Conclusions: These methods can be used to estimate direct and indirect causal effects in
a mediation setting, and have potential for the investigation of more complex networks
between multiple interrelated exposures and disease outcomes.
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Introduction
The technique of Mendelian randomization is being exten-
sively applied to estimate the long-term causal effects of
various exposures on clinical and epidemiological out-
comes using observational data. It employs genetic variants
to remove bias due to confounding and reverse causation.1
These variants must satisfy the assumptions of an instru-
mental variable (IV): association with the exposure of
interest; lack of association with any confounder of the ex-
posure–outcome relationship (including those that are un-
measured); and lack of conditional association with the
outcome given the exposure and all the confounders.2 Such
a genetic variant divides the observed population into sub-
groups which differ systematically with respect to the ex-
posure of interest and any causal descendants thereof, but
not with respect to potential confounding variables.3 These
subgroups are analogous to arms in a randomized con-
trolled trial where the intervention is to change the level of
the exposure.4
The usual scenario investigated in Mendelian random-
ization is given in the causal directed acyclic graph (DAG)
of Figure 1, which illustrates the assumed relations be-
tween the genetic variant, exposure, outcome and con-
founders.5 The observational correlation between the
exposure and the outcome does not have a causal interpret-
ation, due to the presence of confounding variables, which
may be unobserved. The IV assumptions about the rela-
tionship of the genetic variant with the other variables en-
able identification and consistent estimation of the causal
effect of the exposure on the outcome.6 In fact, unlike
Figure 1, a genetic variant used in a Mendelian randomiza-
tion analysis need not necessarily be causally related to the
exposure; it may be a proxy for the true causal variant.
Any variant in linkage disequilibrium (meaning correlated
in its distribution) with the causal variant which satisfies
the IV assumptions can be used as an IV.77
As genetic research progresses, the number of risk factor
variables (exposures, biomarkers or other potential risk
factors) with associated genetic variants, where there is
enough biological knowledge to use the variants as IVs, is
rapidly increasing.8 If multiple risk factors with associated
IVs have been measured in the same dataset, then the
causal effect of each of the risk factors on the outcome can
be estimated. Additionally, each of the risk factors can be
considered as the outcome in an IV analysis, and the causal
effects of the risk factors on each other can be estimated.
Such estimates could give insight into the causal network
of relations between multiple risk factors, which is inform-
ative about the mechanisms between them and the
outcome.9 This has been proposed in the context of inte-
grating data on genetic variants with ‘omics’ data, such as
data on gene expression, epigenetic markers and metabol-
ites.10 Potential areas of application of this technique in
high-throughput datasets are considered in the discussion.
In this work, we seek to extend conventional Mendelian
randomization analysis by considering a simple causal net-
work of risk factors. We suppose that the causal effect of
an exposure on an outcome is partially mediated by an-
other risk factor. The total effect of the exposure on the
outcome can therefore be decomposed into a direct and an
indirect effect.11,12 The direct effect of the exposure is the
effect on the outcome of manipulating the exposure while
the mediator remains unchanged. If this is achieved by fix-
ing the mediator at a given value for all individuals, then
this is a controlled direct effect. If it is achieved by letting
the mediator take the value it would have taken if the
Key Messages
• When instrumental variables are available for an exposure and mediator in a causal network, the direct and indirect
effects of the exposure on an outcome, controlling for the mediator, can be estimated in the presence of unmeasured
confounding in the model considered. The direction of causal effect between the exposure and mediator can also be
verified.
• Formally, strong assumptions of linearity without interaction and homogeneity of causal effects are required for the
consistency of estimators, although simulation analyses suggest that estimates may be robust to substantial random
heterogeneity.
• The methods presented have potential application in the context of Mendelian randomization for the estimation of
causal networks.
Genetic
variant Exposure
Confounders
Outcome
Figure 1. Causal directed acyclic graph (DAG) of Mendelian randomiza-
tion assumptions.
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exposure were unchanged (which will differ between indi-
viduals), then this is a natural direct effect. The natural in-
direct effect is the residual effect on the outcome of the
change in the mediator attributable to a change in the ex-
posure.13 Formal definitions of these quantities require the
mathematical language of counterfactuals, and are given in
the Web Appendix (available as Supplementary data at IJE
online). To give a motivating example, the causal effect of
smoking on coronary heart disease risk may be partially
mediated by the effect of smoking on blood pressure. If the
mediation is substantial and the direct effect of smoking on
heart disease is small compared with the total effect, then
an intervention on blood pressure may be as effective to re-
duce heart disease risk among smokers as an intervention
on smoking itself. We note that the term ‘direct effect’ de-
pends on the choice of the mediator, as the effect includes
pathways which are not direct in any absolute sense, but
are mediated by variables other than the mediator under
consideration.
The structure of this paper is as follows. We first discuss
two methods to estimate direct and indirect effects using
genetic variants as IVs for the exposure and the mediator.
The methods are initially presented informally, followed
by a technical discussion of the parameters estimated and
the necessary assumptions. We then illustrate the applica-
tion of the methods in a simulation study and in an applied
example, paying particular attention to the impact on ef-
fect estimates of violations of parametric assumptions
(such as linearity and constant effects across individuals),
and conclude with a discussion of the limitations of the
methods and their future potential.
Methods
We consider the causal effect of an exposure X on an out-
come Y with a mediator Z. The exposure and mediator
each have corresponding genetic IVs, GX and GZ respect-
ively. A causal DAG illustrating the relationships between
these variables is given in Figure 2. We consider the situ-
ation where the exposure, mediator and outcome are all
continuous and assume that the effects of the exposure on
the mediator (X on Z), and of the exposure and mediator
on the outcome [(X, Z) on Y] are linear without inter-
actions. Similar methods could be used in a case of a binary
exposure, mediator and/or outcome, but we do not address
the additional complications of non-collapsibility that arise
in this paper.14,15 We allow unmeasured confounding of
the exposure–mediator, exposure–outcome and mediator–
outcome relationships. This is indicated by a single vari-
able U on the DAG; however, this can be thought of
as a vector containing several components corresponding
to different confounders, some of which may not be
associated with all of X, Z and Y. For simplicity of pres-
entation, the DAG in Figure 2 does not include ‘post-
treatment confounders’.16 These are confounders of the
relationship between the mediator and outcome which are
affected by changes in the exposure, and are discussed in
the next section.
We discuss two methods for the estimation of direct
and indirect effects: a regression-based method, which can
be understood by those already familiar with standard IV
methods for Mendelian randomization as a repeated
application of the ratio method or as an extension of the
two-stage least squares method; and a structural equation
modelling approach, which is more easily generalizable to
more complex causal networks.
Regression-based methods
The ratio method (or Wald method) is a simple method for
estimating a total causal effect with a single IV. The coeffi-
cient from the regression of the outcome on the exposure’s
IV (b^YjGX ) is divided by the coefficient from the regression
of the exposure on the IV (b^XjGX ):
b^X!Y ¼
b^YjGX
b^XjGX
(1)
where ! represents a total causal effect.17 The same esti-
mate can be obtained using the two-stage least squares
(2SLS) method, by regressing the exposure on the IV to ob-
tain fitted values of the exposure (X^jGX), and then regress-
ing the outcome on these fitted values.18 The 2SLS method
can also be used with multiple IVs. The ratio estimate has
been named the linear IV average effect as it represents the
causal effect of the exposure on the outcome averaged
across the population on a linear scale.3
If all effects are linear without interaction terms, the
natural direct effect of X on Y not mediated by Z can be
obtained, under the assumption of homogeneity of causal
effects across individuals in the population, as the differ-
ence between the total effect of X on Y and the product of
the effects of X on Z and Z on Y.19 The causal effects of X
GX X Y
ZGZ
U
Figure 2. Causal directed acyclic graph (DAG) leading to direct and in-
direct causal effects of variable X on Y with mediator Z, associated in-
strumental variables GX and GZ, and confounders U.
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on Z and of Z on Y can each be estimated by application
of the ratio method, so the natural direct causal effect is:
b^X)Y ¼ b^X!Y  b^X!Zb^Z!Y
¼ b^YjGX
b^XjGX
 b^ZjGX
b^XjGX
b^YjGZ
b^ZjGZ
(2)
where ) represents a natural direct effect. The natural
indirect effect is b^X!Zb^Z!Y . The standard error and confi-
dence intervals for these quantities can be estimated by
bootstrapping. If the natural direct effect is constant with
respect to the mediator for all individuals, then it is equal
to the controlled direct effect for all values of the medi-
ator.13 We therefore henceforth omit the reference to nat-
ural or controlled direct effects in the context of linear
models without interactions unless we are specifically dif-
ferentiating between the two.
If there are post-treatment confounders U* (Figure 3),
then the natural direct effect cannot in general be identified
(even if these variables are measured20) without further as-
sumptions.21 Maintaining the assumption that effects are
linear without interaction terms, the total causal effect of
X on Y can be further decomposed into:
b^X!Y ¼ b^X)Y þ b^X!U b^U)Y þ b^X)Zb^Z!Y
þb^X!U b^U!Zb^Z!Y
¼ ðb^X)Y þ b^X!U b^U)YÞ
þðb^X)Z þ b^X!U b^U!ZÞb^Z!Y
(3)
which is simply the sum of the direct and indirect effects as
before. Therefore, we can omit specific reference to post-
treatment covariates in the context of linear models with-
out interactions.
Similar estimates of the direct and indirect effects cor-
responding to equation (2) can also be obtained by a ‘mul-
tiple-stage least squares’ approach, where the first stage is
to obtain fitted values of the exposure on its IV (X^jGX),
then to obtain fitted values of the mediator regressed on its
IV and the fitted values of the exposure ½ (Z^jðGZ; X^jGXÞ)],
and the final stage is to regress the outcome on the fitted
values X^jGX and Z^jðGZ; X^jGXÞ. This approach is
discussed by Tchetgen Tchetgen and Lin,22 who give a jus-
tification of the method starting from the non-parametric
structural equation modelling framework of Pearl.23
Structural equation models
Alternatively, parameters in this causal network and other
more complex networks can be estimated using structural
equation models (SEMs). SEMs are used extensively in the
social sciences for inference on the network of associations
between variables.24 A SEM is a compound hypothesis
about the relations between measured and latent variables
as encoded in a path diagram. Assuming that the path dia-
gram is correctly specified, coefficients from a SEM can be
viewed as representing causal effects, although the causal
nature of the estimates is by prior assumption rather than
being empirically established by the data.25 IV analysis can
be performed in a SEM framework as the IV assumptions
can be used to define a causal path diagram under which
the data can be analysed. Relations between variables can
be represented by directed arrows, indicating a causal ef-
fect, often assumed to be linear, or bidirectional arrows,
indicating a correlation between variables. Measured vari-
ables are represented by squares, and latent variables,
including measurement error terms, by circles. In the IV
path diagram (Figure 4) corresponding to the DAG in
Figure 1, the unmeasured confounding between the expos-
ure (X) and the outcome (Y) is modelled by allowing cor-
relation in the path diagram between their respective error
terms X and Y .
To estimate direct and indirect effects in a SEM frame-
work, we assume a path diagram corresponding to
Figure 5. This is similar to Figure 2 except that the unmeas-
ured confounding is expressed as a correlation between the
error terms X, Z and Y . The model is identified by the
directional assumptions about the effects of the IVs on the
variables which they instrument. The coefficients in the
SEM represent the direct effects between individual vari-
ables. The indirect effect of X on Y via Z can be calculated
under the assumptions of linearity and homogeneity of
X Y
Z
U*
Figure 3. Causal directed acyclic graph (DAG) illustrating direct and in-
direct causal effects of variable X on Y with mediator Z with post-treat-
ment confounder U*.
Figure 4. Path diagram for estimation of causal effect of exposure (X)
on outcome (Y) in the presence of unmeasured confounding using in-
strumental variable (G).
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effects without interactions either by estimating the total
effect of X on Y assuming the path diagram of Figure 4
and subtracting the direct effect, or (as in this paper) by
multiplying the coefficient for the causal effect of X on Z
by that for the causal effect of Z on Y.
In this work, we use the sem function in Stata 1226 for
SEM analyses, estimating parameters by maximum likeli-
hood. In the conventional IV setting (Figure 1), this is also
known as full information maximum likelihood (FIML).27
Confidence intervals can be constructed based on asymptotic
standard errors. A standard error for the indirect effect can
be calculated from the delta method in Stata using the nlcom
function. A useful feature of SEMs is the availability of tests
for assessing goodness-of-fit of the model.28 Estimation of
parameters and many goodness-of-fit tests rely on the as-
sumption of multivariate normality of the variables.29
Direction of the causal effect
In the set-up of Figure 2, but where it is uncertain whether
Z is a mediator of X or vice versa, it is additionally possible
to test for a causal effect between X and Z in both direc-
tions. IVs for X can be used to estimate the causal effect of
X on Z, and IVs for Z can be used to estimate the causal ef-
fect of Z on X. These estimates can be used to orientate the
direction of causal effect (if any) between the exposure and
mediator. Such an analysis has been named ‘reciprocal
Mendelian randomization’.30
As genetic subgroups of a population defined by an IV
represent subpopulations with long-term average differences
in the exposure of interest,31 the causal effects estimated in
a Mendelian randomization analysis represent long-term re-
lationships, equivalent to a randomized trial where the
intervention is made at conception. As such, changes in the
effects of the exposure and mediator over time and feedback
between the exposure and mediator cannot be addressed by
a conventional Mendelian randomization analysis. This has
consequences for the interpretation of all Mendelian
randomization estimates,32 and particularly in a mediation
setting, where a ‘bidirectional’ causal relationship between
X and Z may reflect an effect of (say) X on Z in early life,
and Z on X in later life. Ideally in mediation analyses, biolo-
gical knowledge should be used to provide a causal ordering
of the exposure, mediator and disease. Where this is not
possible, reciprocal Mendelian randomization approaches
may provide evidence on the direction of causal effects, al-
though all such estimates rely on the assumption that these
effects do not vary in direction over time.
Technical issues
Although the concepts of a direct and indirect effect can be
understood intuitively, precise definitions depend on
exactly how the interventions on the exposure and medi-
ator are performed.11,13 A controlled direct effect is the
effect of increasing the exposure when the mediator is set
to be fixed at a given level. A natural direct effect is the ef-
fect of increasing the exposure when the mediator is left at
the level it would have taken had the exposure been
observed at its reference value. The controlled direct effect
is an appealing quantity as it can be estimated as the result
of an experiment when the levels of the exposure and me-
diator can be separately manipulated. The natural direct
effect requires an estimate of the outcome as if the expos-
ure were intervened on, but the mediator took its value as
if the exposure took a different value. This is intrinsically a
counterfactual quantity, and as such cannot be observed
from any experiment.33 However, the natural direct effect
has a counterpart natural indirect effect: the effect of
increasing the mediator from the level it would take if the
exposure took its reference value to the level it would take
if the exposure were increased, keeping the exposure at its
elevated level. The total effect of the exposure on the out-
come is equal to the sum of the natural direct and indirect
effects.11,13 These definitions are discussed further in
the Web Appendix (available as Supplementary data at IJE
online).
The method of IVs exploits a natural experiment,
enabled by the random distribution of the IV in the popula-
tion. The IV acts to change the variable which it instru-
ments. In the context of mediation, the use of separate IVs
for X and for Z can be viewed as separate experiments to
set the values of X and Z,34 and so using IVs in a non-
parametric setting to estimate the distributions of the ex-
posure and mediator would allow the calculation of a con-
trolled direct effect. However this is equal to the natural
direct effect in the linear setting if the controlled direct ef-
fect is constant for all values of the mediator, that is if there
is no interaction between X and Z in their effect on Y.13 In
contrast, the analogous parallel design approach of Imai
et al., in which two experiments are performed to affect
the values of the exposure and mediator separately, is
Figure 5. Path diagram for estimation of causal direct and indirect ef-
fects of exposure (X) on outcome (Y) with mediator (Z) in the presence
of unmeasured confounding using instrumental variables (GX,GZ) in a
structural equation model (SEM) framework.
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proposed to target a natural direct effect parameter (al-
though different views were expressed as to the appropri-
ate target parameter in the commentary on the paper).34
However the authors make the same no-interaction as-
sumption as stated above, rendering this discussion to a
large degree a question of philosophical preference rather
than one having any applied consequence. In the context
of Mendelian randomization, where exposure and medi-
ator variables are usually continuous, the assumption of
linear effects is often made to allow the presentation of a
single effect estimate for all levels of the variable of
interest.
The reliance on separate experiments and the decom-
position of the indirect effect into the product of separate
effects on the mediator and outcome can lead to incorrect
inferences if the causal effects of X on Z and of Z on Y
vary substantially for different individuals in the popula-
tion. This is known as the fallacy of the causal chain ap-
proach35 It is even possible for the average causal effects of
the exposure on the mediator and of the mediator on the
outcome to be positive, but for the average indirect effect
to be negative. This is an analogous problem to Simpson’s
paradox, whereby the average effect in the population can
be in the opposite direction to the average effects in each of
the substrata of the population.36,37 Hence the use of IVs
for both the exposure and the mediator formally requires
the assumption of homogeneity across individuals of the
effects of a unit change in the exposure on the mediator
and on the outcome, as well as of a unit change in the me-
diator on the outcome. As linearity is assumed here, these
effects are also required to be constant for all values of the
exposure and mediator.
Simulations
We now perform a simulation study to demonstrate the
use of the two methods discussed above, regression-based
and SEM, to provide estimates of direct and indirect ef-
fects. We also use these simulations to assess the impact of
heterogeneity of causal effects on these estimates. Data
were simulated on 5000 individuals indexed by i from the
following plausibly realistic data-generating model, corres-
ponding to Figures 2 and 5:
The IVs GX and GZ are modelled to correspond to bial-
lelic genetic variants (taking values 0, 1, 2) with a minor
allele frequency of 0.3. The U variables represent con-
founders in the associations between the exposure, medi-
ator and outcome. X and Z take both positive and negative
values.
The causal effects are allowed to vary between individ-
uals; for example the causal effect of X on Z (bXi) has
mean lbX and standard deviation s; s¼ 0 corresponds to
no variability between individuals (homogeneity), and
s> 0 to variability (heterogeneity). We set lcX¼1 through-
out, so that the average direct effect is 1 in all scenarios,
and take lbX, lcZ¼61. The average indirect effect is
lbXlcZ. Three values of s
2 are considered: 0, 0.22 and 0.42,
representing respectively no, moderate and substantial het-
erogeneity. So 12 scenarios are considered in total. We set
aG¼ 0.3, and bG¼ 0.5, when lbX¼ 1 and bG¼ 0.36 when
lbX¼1, so that the averageproportion of the variance in
X and Z explained by the IVs GX and GZ, respectively,
(the coefficient of determination, R2) is 1.3% in all scen-
arios. With a sample size of 5000, this corresponds to aver-
age F statistics of around 65, so the potential of bias from
weak instruments is small.38
The impact of interaction between X and Z in the gen-
erating model for Y is considered in the Web Appendix
(available as Supplementary data at IJE online): first by
adding an interaction term with zero mean but non-zero
variance, so that there is interaction between X and Z on
an individual level, but not on average; and then by adding
an interaction term with non-zero mean. Additionally, the
impacts of heterogeneity in the genetic effects of GX and
GZ on X and Z, respectively, and of correlation in the
causal effects between X, Z and Y, are considered.
Results
For each set of parameter values, 1000 datasets were gen-
erated. The causal effects of X on Z and of Z on X were
estimated using the ratio method, and the direct and indir-
ect effects of X on Y for the mediator Z were estimated
using regression-based and SEM methods. Out of the
12 000 datasets, using a 5% significance level, a causal
xi ¼ aGgXi þ u1i þ u2i þ Xi
zi ¼ bGgZi þ bXixi þ u1i þ u3i þ Zi
yi ¼ cXixi þ cZizi þ u2i þ u3i þ Yi
bXi  N lbX; s2
 
; cXi  N lcX; s2
 
; cZi  N lcZ; s2
 
independently
gXi; gZi  Binomial 2; 0:3ð Þ independently
u1i; u2i; u3i; Xi; Zi; Yi  Nð0;1Þ independently
(4)
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effect of X on Z was found in all but seven datasets
(>99.9%). A causal effect of Z on X was found in 4.8% of
datasets, which is no more than would be expected by
chance alone. Mean estimates of the direct and indirect ef-
fects across simulations are given in Table 1, as well as the
mean standard error of estimates (in the regression-based
analyses, standard errors were calculated by bootstrapping
with 1000 bootstrap resamples; in the SEM analyses, they
were calculated analytically), and the standard deviation of
estimates. The Monte Carlo standard error of the mean es-
timates, representing the uncertainty due to the finite num-
ber of datasets, is around 0.005.
Both methods appear to estimate the average direct and
indirect effects without substantial bias, even when there
is individual-level heterogeneity of effects (s2>0). The
mean standard errors agreed well with the empirical
standard deviations of the estimates. Estimates using the
SEM method seemed to be more efficient, with estimates
having lower mean standard errors than those from the re-
gression-based method. This corresponds to the stronger
distributional assumption of multivariate normality,
which is satisfied in this example, made by the SEM
method. A similar finding of no substantial bias was found
when there was a zero mean interaction between X and Z
in the model for Y (Web Table A1, available as
Supplementary data at IJE online), although some bias
was observed when the interaction term had non-zero
mean (Web Table A2, available as Supplementary data at
IJE online). Under heterogeneity in the genetic effects on
the exposure and mediator, results were not materially dif-
ferent to those in the original simulation (Web Table A3,
available as Supplementary data at IJE online). Under cor-
relation in the causal effect parameters bXi, cXi, cZi, there
was a slight bias in estimates of the direct effect in the
direction of the correlation when there was substantial
heterogeneity in the parameters, but no evident bias in
Table 1. Mean estimates, mean standard errors (SE) and standard deviations of estimates (SD) of the direct and indirect effects
of X on Y controlling for Z; from regression-based and structural equation model (SEM) methods in simulation study:
lcX ¼ average direct effect of X on Y, lbX ¼average effect of X on Z, lcZ ¼average effect of Z on Y, lbXlcZ ¼ average indirect ef-
fect of X on Ymediated by Z, s¼heterogeneity in individual-level causal effect parameters
Regression-based
Direct effect (lcX ¼ 1) s2¼0 s2¼0.22 s2¼0.42
lbX lcZ Mean SE SD Mean SE SD Mean SE SD
1 1 1.00 0.19 0.19 1.01 0.20 0.19 1.00 0.23 0.22
1 1 1.01 0.20 0.18 1.00 0.20 0.19 1.00 0.23 0.23
1 1 1.00 0.22 0.21 1.01 0.23 0.22 1.00 0.26 0.25
1 1 1.01 0.23 0.21 1.00 0.24 0.22 1.00 0.26 0.24
Indirect effect (lbXlcZ) s
2¼0 s2¼0.22 s2¼0.42
1 1 0.98 0.20 0.19 0.98 0.20 0.19 0.98 0.21 0.20
1 1 1.01 0.20 0.19 1.01 0.20 0.19 1.01 0.21 0.21
1 1 1.02 0.22 0.22 1.01 0.23 0.22 1.02 0.25 0.24
1 1 0.99 0.23 0.21 1.00 0.23 0.23 1.00 0.25 0.24
Structural equation models (SEM)
Direct effect (lcX ¼ 1) s2¼0 s2¼0.22 s2¼0.42
lbX lcZ Mean SE SD Mean SE SD Mean SE SD
1 1 0.99 0.15 0.15 0.99 0.16 0.16 0.99 0.19 0.19
1 1 1.00 0.15 0.15 0.99 0.16 0.16 0.99 0.19 0.19
1 1 1.00 0.16 0.16 1.00 0.17 0.17 0.99 0.20 0.20
1 1 0.99 0.17 0.17 0.99 0.17 0.17 0.99 0.20 0.20
Indirect effect (lbXlcZ) s
2¼0 s2¼0.22 s2¼0.42
1 1 0.99 0.15 0.15 1.00 0.15 0.16 0.99 0.17 0.17
1 1 1.00 0.15 0.15 1.00 0.15 0.15 1.01 0.17 0.17
1 1 1.01 0.16 0.16 1.00 0.17 0.17 1.01 0.19 0.19
1 1 1.01 0.17 0.17 1.01 0.17 0.17 1.01 0.19 0.19
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estimates of the indirect effect (Web Table A4, available
as Supplementary data at IJE online).
We conclude that estimates of the direct and indirect ef-
fects using the methods presented in this paper are robust
to quite substantial random heterogeneity in the causal
and genetic effects, and to random (zero mean) individual-
level interaction, in the range of simulation examples
considered.
Example: body mass index, C-reactive
protein and uric acid
To illustrate these approaches, we consider the causal rela-
tionships between body mass index (BMI, kg/m2),
C-reactive protein (CRP, mg/l) and uric acid (mg/dl).
Previous research has shown that genetic variants associated
with BMI are associated with CRP levels30,39 and associated
with uric acid concentrations,40 although in both cases the
reverse was not found for genetic variants which are plaus-
ible IVs for CRP and for uric acid. We verify the directions
of causal effects between these variables, and additionally
consider the direct and indirect causal effects of BMI on uric
acid using CRP as a potential mediator. Data were taken on
7158 subcohort participants from 20 centres of European
ancestry from the EPIC-InterAct study,41 a multicentre case-
cohort study of type 2 diabetes nested within the European
Prospective Investigation into Cancer and Nutrition (EPIC)
with complete data on the three variables (BMI, CRP, uric
acid). To simplify the analysis, a weighted allele score was
constructed out of the genetic variants for each of the vari-
ables.42 Details of the genetic variants and the construction
of the allele scores are given in the Web Appendix (available
as Supplementary Data at IJE online). CRP was log-trans-
formed throughout.
The coefficients, standard errors, and P-values from the
regressions of each of the variables on an allele score for
each of the other variables are given in Table 2. In each re-
gression, adjustment is made for age, sex and centre. Allele
scores are scaled so that the coefficient of each allele score
in the regression on the variable it instruments is 1. The al-
lele score for BMI is associated with CRP (P¼ 0.009),
whereas the allele score for CRP is not clearly associated
with BMI (P¼ 0.17), suggesting that increases in BMI
cause increases in CRP levels, but the opposite is not true.
The allele score for BMI is not associated with uric acid
(P¼ 0.12), although the direction of the association is con-
sistent with that previously observed.40 The allele score for
uric acid is not associated with BMI (P¼0.57). Using
equation (2), the direct effect of BMI on uric acid not via
CRP is 0.053 (standard error 0.035). This is similar to the
total effect of 0.052 (0.032). The indirect effect is 0.001
(0.016). Using the multiple-stage least squares method,
again adjusting for age, sex and centre in all the regression
stages, the estimates of total, direct and indirect effect are
0.052 (0.033), 0.053 (0.037) and 0.001 (0.017), respect-
ively. Using the structural equation modelling approach,
we first standardized the measures of BMI, CRP and uric
acid by adjusting for sex, age and centre. This was because
there was poor convergence in the SEM algorithm due to
the large number of covariates. Estimates of total, direct
and indirect effect are 0.052 (0.032), 0.048 (0.034) and
0.004 (0.013), respectively. Similar results were obtained
from all three estimation approaches. We conclude that
any effect of BMI on uric acid concentrations does not
seem to be mediated via CRP levels.
Discussion
In this paper, we have considered the assessment of the dir-
ection of effect between two variables, and the estimation
of direct and indirect effects using genetic variants as in-
strumental variables for the exposure and mediator. The
regression-based and SEM methods discussed in this paper
give similar estimates, which are consistent in the presence
of unmeasured confounding, under the instrumental vari-
able assumptions together with further assumptions on the
linearity of effects without interaction terms and on the
homogeneity of individual-level effects of the exposure on
the mediator and the exposure and mediator on the out-
come. A simulation study suggests that random heterogen-
eity in the effects between the exposure, mediator and
outcome does not lead to substantial bias in the estimators
of the direct and indirect effects for the wide range of data-
generating mechanisms considered; although there was
some bias when variability in the individual-level effect
parameters was correlated. Additional sensitivity analyses
Table 2. Coefficients (standard errors) and P-values from regression of body mass index (BMI), C-reactive protein (CRP) and uric
acid on allele scores for each of the variables in turn. Adjustment is made for sex, age, and centre
Score BMI P-value CRP P-value Uric acid P-value
Allele score for BMI 1.00 (0.12) <0.001 0.08 (0.03) 0.009 0.05 (0.03) 0.12
Allele score for CRP 0.83 (0.61) 0.17 1.00 (0.16) <0.001 0.01 (0.17) 0.95
Allele score for uric acid 0.12 (0.21) 0.57 0.05 (0.05) 0.37 1.00 (0.06) <0.001
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could be performed by proposing different data-generating
models; those considered in this paper were chosen as they
were thought to be the most likely to occur in applied ex-
amples. The methods were illustrated in an applied ex-
ample, considering the causal relationships between body
mass index, C-reactive protein and uric acid.
A theoretical example has been demonstrated with ex-
treme patterns of heterogeneity which would lead to mis-
leading results from a mediation analysis using separate
instrumental variables for the exposure and mediator.35
In this example, the effects of the exposure on the medi-
ator and of the mediator on the outcome are in different
directions for subgroups of the population. Further re-
search to show whether the assumptions of homogeneity
of the these effects could be weakened, say to allow hetero-
geneity in the effects provided they were in the same direc-
tion across individuals in the population, would be
valuable to add a theoretical result to the simulation find-
ings of this paper.
Connection to previous literature
The estimation of direct and indirect effects from observa-
tional data has received much attention in the recent statis-
tical and epidemiological literature, as well as in numerous
other fields.19,43–45 The majority of this literature has been
based on the strong and untestable assumption of no
unmeasured confounding (of the mediator–outcome rela-
tionship as well as the exposure–outcome and exposure–
mediator relationships);13 extensive work on sensitivity
analyses in relation to this assumption has also been pub-
lished.46,47 Although restrictive in the sense of requiring
the assumption of no unmeasured confounding, this litera-
ture has succeeded in relaxing many of the other assump-
tions on which earlier papers on mediation analysis relied,
such as no interaction between exposure and mediator,
and the linearity of relationships.
In general, there are two approaches for making causal
inference from observational data: to assume that there are
no unmeasured confounders, or to assume that a variable
acts as an IV. The estimation of direct and indirect effects
using IVs has been previously addressed in the context of
randomized trials (see references 48 and 49 for reviews). In
this setting, random assignment is typically used as the ex-
posure, and the interaction between random assignment
and a baseline covariate as an IV for the mediator
(Figure 6). When using genetic variants as instruments, the
association between the IV and the exposure is often weak,
and thus using the interaction between this variant and a
baseline covariate as an IV for the mediator would typic-
ally result in an even weaker IV for the mediator, leading
to substantial finite sample bias and imprecision, even if all
the IV assumptions were met.50 Instead, we have focused
on situations in which a different genetic variant can be
used as an IV for the mediator. This is a situation similar
to that considered by Imai et al. in the context of random-
ized trials34 with the first randomization affecting the
treatment assigned (analogous to the IV for the exposure)
in the whole population, and the second randomization af-
fecting the level of the mediator (analogous to the IV for
the mediator) performed in a subsample of participants.
In Mendelian randomization, the genetic variant is not
permitted to have an effect on the outcome except via the
exposure. Whereas it is possible to consider the direct and
indirect effects of a genetic variant on a disease outcome
(for example in reference 51), the aim of Mendelian ran-
domization is not to estimate the effect of genes, but the
effect of modifiable risk factors on outcomes. Figure 6
illustrates the difference between the use of IVs for medi-
ation analysis in a randomized trial and the Mendelian ran-
domization scenario considered in this paper.
This means that, in the context of randomized
trials where the interaction between random assignment
and a baseline covariate is used as an IV for the medi-
ator, the assumption of homogeneous effects across indi-
viduals is less fundamental than in the Mendelian
randomization context considered in this paper. This is be-
cause in a randomized trial, only a single randomization
‘experiment’ is performed. A proposal has been put for-
ward to weaken the assumption of homogeneous effects in
the context of randomized trials, replacing it with more
plausible assumptions that can be assessed by sensitivity
analyses.49
The use of instrumental variables provides a valuable
addition to mediation analysis by relaxing the no unmeas-
ured confounding assumption, but it does so at the cost of
reintroducing these stronger assumptions of linearity and
no interaction, a trade-off which must carefully be eval-
uated in any given context.52 Interactions between the ex-
posure and mediator could be modelled in a multiple-stage
least squares framework,22 but were not considered in this
paper.
(i)
(ii)
Figure 6. Diagram illustrating mediation scenarios: (i) typically investi-
gated in the context of a randomized trial, (ii) proposed in this paper,
with GX and GZ representing genetic variants used as instrumental vari-
ables. Confounding variables are omitted from the diagram.
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Violation of the instrumental variable
assumptions
Throughout, we have assumed that genetic variants are
available which satisfy the IV assumptions for the expos-
ure–mediator and mediator–outcome relationships. This
means that an association between the mediator and IVs
for the exposure is interpreted as a causal effect of the ex-
posure on the mediator. In practice, it is possible that such
associations may reflect pleiotropy (multiple effects of a
single gene) rather than mediation. If there are alternative
pathways by which variants associated with the exposure
may be associated with the mediator, then the assessment
of mediation is more problematic. We recommend that in-
vestigations into the mediation and the direction of causal
effects use genetic variants only where the IV assumptions
have a strong biological or scientific basis.
More complex networks and model selection
The methods and principles used in this paper could be em-
ployed to investigate more complex causal networks, either
by repeated application of mediation analysis and assess-
ment of the direction of causal effects, or by analysis of a
more complex SEM. In many cases, the target of investiga-
tion is not the estimation of causal effects, but inference on
the underlying set of causal relationships between vari-
ables. In a SEM framework, this can be done by testing a
series of candidate models. A range of different tests is
available in most SEM estimation programs, or standard
goodness-of-fit criteria can be used, such as the Akaike in-
formation criterion (AIC) or Bayesian information criter-
ion (BIC).28 In a Bayesian framework,27 additionally the
deviance information criterion (DIC)53 or the posterior
probabilities of models can be compared, for example
using Bayes factors.54 A similar approach has been sug-
gested to distinguish between causal, reactive and inde-
pendent models of association using a likelihood-based
approach based on the AIC.55 Although not all causal
models can be distinguished on the basis of observational
data, models which have different conditional independ-
ence structures result in joint distributions for the variables
which can be empirically compared.56,57
Such methods may be useful in large scale ‘omics’ data,
such as gene expression data (genomics), methylation data
(epigenomics), protein data (proteomics) and transcription
data (transcriptomics).58 Integration of multiple layers of
‘omics’ data may give us insight into the relations between
biomarkers in different layers. Examples of such
approaches have been named ‘genetical genomics’ (integra-
tion of genetic variants and gene expression data)59 and
‘genetical epigenomics’ (integration of genetic variants and
epigenetic data).60 A practical application of the integra-
tion of ‘omics’ data with phenotypic and disease data is
documented in the paper of Wan et al.61—investigating
associations between cigarette smoking behaviours and
disease outcomes with DNA methylation to search for
mechanisms by which an increased risk of smoking-related
diseases may persist even after cessation of smoking.
Relationships between epigenetic markers, transcription
factors and proteins can be affected by confounding and
reverse causation in the same way as relationships between
phenotypic exposures and outcomes. Although the causal
network is generally high-dimensional and unknown, the
direction of potential causal relationships between layers
of data can often be deduced from external biological
knowledge. Relton et al.10 proposed a similar analytical
approach that considered, in this paper under the name
‘two-step epigenetic Mendelian randomization’, using
separate genetic variants as instrumental variables for a
phenotype (exposure) and an epigenetic marker (medi-
ator), to investigate mediation. A key difficulty here is find-
ing genetic variants specifically associated with the
phenotype and with the epigenetic marker if the two vari-
ables are closely biologically related.
Supplementary Data
Supplementary data are available at IJE online.
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